Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

IGILUC 2019 /
SBRT photons, protons or carbon for prostate cancer: How good is the data?

18th - 19th Apr 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 09.05.19
Views: 705
Rating:

Prof Mach Roach III - University of California, San Francisco, USA

Prof Mach Roach III speaks to ecancer at the 2019 International Gastrointestinal, Liver and Uro-Oncology Conference (IGILUC) in Cairo about the recent advances in radiotherapy for the treatment of prostate cancer.

He explains the application of stereotactic body radiotherapy (SBRT) along with the advantages associated with this technique.

Prof Roach III also describes the use of alternative types of radiotherapy, which are currently being explored and include proton, carbon and X-ray radiation.

For the future, he hopes that the use of particle radiotherapy will offer minimal side effects for these types of patients.

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation